Showing results (1681-1690 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|January 11, 2016
Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling AnalysisEdouard Ledent, Alfons Lieftucht, Hubert Buyse, et al.Drug Safety|January 23, 2016
Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims DatabaseIzyan A Wahab, Nicole L Pratt, Lisa Kalisch Ellett, et al.Drug Safety|January 23, 2016
Social Media Listening for Routine Post-Marketing Safety SurveillanceGregory E Powell, Harry A Seifert, Tjark Reblin, et al.Drug Safety|January 1, 2016
Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR ReportsKevin Klein, Joep H G Scholl, Niels S Vermeer, et al.Drug Safety|October 9, 2015
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future NeedsNikolai PetrovskyDrug Safety|September 16, 2015
Drug-Induced Hyperglycaemia and DiabetesNeila Fathallah, Raoudha Slim, Sofien Larif, et al.Drug Safety|November 1, 2015
Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future PerspectivesSteen Husted, Freek W A Verheugt, Willemijn J ComuthDrug Safety|March 23, 2016
The Safety of Metoclopramide in Children: A Systematic Review and Meta-AnalysisMelissa Lau Moon Lin, Paula D Robinson, Jacqueline Flank, et al.Drug Safety|February 17, 2016
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP)Manfred Hauben, Jeffrey K Aronson, Robin E FernerDrug Safety|August 29, 2015
Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-AnalysisAlice Capogrosso Sansone, Stefania Mantarro, Marco Tuccori, et al.Pageof 311